← FDA DRUG APPROVALS

FDA ANDA · ANDA201509

ZOLPIDEM TARTRATE

Sponsor: PH HEALTH

APPLICATION
ANDA201509
TYPE
ANDA
ORIGINAL APPROVAL
2016-08-01
LATEST ACTION
2019-11-15
ROUTE
SUBLINGUAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ZOLPIDEM TARTRATEPrescription
ZOLPIDEM TARTRATE 10MG · TABLET · SUBLINGUAL
ZOLPIDEM TARTRATEPrescription
ZOLPIDEM TARTRATE 5MG · TABLET · SUBLINGUAL

Approval history

2019-11-15Labeling · Supplement 1 · standardAP
2019-11-15Labeling · Supplement 2 · standardAP
2016-08-01Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →